Stock fact sheet · data as of

Doximity, Inc. (DOCS): fair value, margin of safety and Wheel Score

Healthcare · Medical - Healthcare Information Services · United States · Blend

Close31.50
GLS fair value25.038 of 9 models
Margin of safety-26%price above fair value
Wheel Score60Fairout of 100
Health6/9Piotroski F-score
Moat8.3/10GLS 10-year score
Market cap$5.6B3.1M shares a day
Implied vol.85%near-the-money, 20-60 d
P/E34.4EPS 0.91
Dividend yieldnone
Beta1.22moves more than the market
Next earnings5 Nov 2026in 20 days (after the close)

Is DOCS undervalued?

At 31.50 (close of 16 Oct 2026), DOCS trades 26% over the GLS average fair value of 25.03. 2 of the 8 models land above the price and 6 below. A negative margin of safety costs Value points in the Wheel Score (2 of 25 here) - the models see no discount, which does not make the business a poor one, only the price a full one.

There is a wide gap between Lynch (10.12) and Payback Time (50.93). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files DOCS under Blend.

Nine valuation models for DOCS

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF25.95-18%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number10.16-68%The most a defensive investor pays for the earnings and book value per share
Graham Growth27.40-13%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch10.12-68%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth25.98-18%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap39.50+25%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time50.93+62%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV10.17-68%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)4.33-86%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target27.00-14%Analysts' average 12-month price target. Not in the average

Quality and financial health

Doximity, Inc. scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 8.3/10 puts DOCS among the more durable businesses we track: over ten years the metrics the score watches (revenue, EPS, book value, margins, cash flow, ROIC) have mostly moved the right way, year after year.

Returns on capital are high - ROIC 20.4%, ROE 20.6%, ROA 17.4% - with debt at 0.01 times equity and a free-cash-flow yield of 5.3%.

Doximity, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Subscription 93%, Service, Other 7% (quarter Q1 FY2027).

Institutional ownership scores 9/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales; the last recorded insider buy was on 24 Sep 2026.

Piotroski F-score6 / 9ROIC20.4%
GLS Moat8.3 / 10ROE20.6%
Debt / equity0.01ROA17.4%
Free-cash-flow yield5.3%Payout ratio0%
Institutions9 / 10Insiders · Congress1 · 5 / 10

Wheel Score 60: Fair

A Wheel Score of 60 puts Doximity, Inc. in the Fair band - below the 70 the Sunday Scan requires. Value 2/25, Health 13/20, Moat 12/15, Premium 14/20 and Stability 19/20; the weakest part is Value (2/25).

Implied volatility is 85% on the near-the-money contracts 20-60 days out - above the 60% ceiling of the sweet spot. Premiums are large, but the Wheel Score tapers the Premium points (14 of 20) because volatility this high usually comes with a reason. Chain open interest is 43,345 contracts across all expiries - enough for the wheel at normal size.

Volume runs at 3.1M shares a day on a market cap of $5.6B, with a beta of 1.22 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 19 of 20.

PartPointsFrom
Value2 / 25-26% margin of safety
Health13 / 20Piotroski 6/9
Moat12 / 15moat 8.3/10
Premium14 / 20implied volatility 85%
Stability19 / 203.1M shares/day, $5.6B cap, beta 1.22

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 5 Nov 2026 (after the close), 20 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Healthcare Information Services

The 12 companies below are the closest to Doximity, Inc. by market cap within the Medical - Healthcare Information Services industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
WAY
Waystar Holding Corp.
26.8738.90+31%85Prime$5.2B
HTFL
Heartflow, Inc. Common Stock
50.91--45Weak$4.4B
HQY
HealthEquity, Inc.
92.51144.55+36%88Prime$7.7B
HNGE
Hinge Health, Inc.
104.9661.09-72%57Fair$8.5B
PRVA
Privia Health Group, Inc.
21.6742.94+50%45Weak$2.8B
TEM
Tempus AI, Inc.
68.32--45Weak$12.0B
BTSG
BrightSpring Health Services, Inc. Common Stock
62.3646.43-34%59Fair$12.3B
OMCL
Omnicell, Inc.
35.9523.57-52%53Fair$1.6B
CERT
Certara, Inc.
9.668.34-16%45Weak$1.5B
GDRX
GoodRx Holdings, Inc.
3.513.44-2%62Fair$1.2B
OMDA
Omada Health
18.674.09-357%52Fair$1.1B
TDOC
Teladoc Health, Inc.
5.8121.97+74%45Weak$1.1B

⚖ Compare DOCS with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about DOCS

Is DOCS undervalued right now?

No: at 31.50 the stock trades 26% above the GLS average fair value of 25.03 (data as of 16 Oct 2026). The margin of safety is negative.

What is the Wheel Score of DOCS and what does it mean?

DOCS scores 60 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.

What is the GLS fair value for DOCS?

25.03 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Doximity, Inc. report earnings next?

The next earnings report is due on 5 Nov 2026 (after the close), 20 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does DOCS have listed options, and how liquid are they?

Yes. The nightly snapshot found 390 listed contracts with 43,345 open interest across all expiries and implied volatility of 85% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.